IGM Biosciences (IGMS) Financials

$1.27

$0.00 (0.00%)

As on 15-Aug-2025 09:30EDT

Market cap

$77 Mln

Revenue (TTM)

$145 Mln

P/E Ratio

--

P/B Ratio

0.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	145.05	2.68	2.13	1.07	0.37	--
Cost of Revenue	2.79	9.11	8.28	10.60	7.72	3.58
Gross Profit	144.61	-6.43	-6.15	1.07	-7.72	-3.58
Operating Expenses	172.46	211.26	265.59	229.03	165.32	83.28
Operating Profit (EBIT)	-27.85	-208.58	-263.46	-227.96	-165.32	-83.28
Other Income	--	--	--	--	0.16	1.93
Profit before Tax	-53.39	-195.80	-245.74	-221.10	-165.16	-81.36
Provision for Tax	--	--	0.68	-6.85	-4.48	-1.03
Profit after Tax (Net Income)	-53.39	-195.80	-246.42	-214.25	-160.68	-80.33
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-221.10	-165.16	-81.36

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	100.93	48.17	203.23	-574.83	-353.72	-188.56
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	179.90	177.70	181.55	25.44	9.58
Current Liabilities	6.06	37.64	42.48	44.69	27.78	17.24
Total Liabilities	113.05	265.71	423.41	513.50	298.13	408.63

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	--	72.09	75.81	75.08	57.38	35.36
Current Assets	106.99	193.62	347.60	438.42	240.75	373.27
Total Assets	113.05	265.71	423.41	-348.59	-300.51	-161.74
Total Debt*	--	45.19	40.51	41.17	28.76	12.24
Net Current Assets	100.93	155.98	305.12	393.74	212.97	356.03

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-153.00	-192.23	-5.85	-124.34	-67.30
Cash Flow from Investing Activities	--	64.16	68.36	-225.64	14.82	57.71
Cash from Financing Activities	--	2.39	115.07	219.38	2.48	214.78
Net Cash Inflow / Outflow	--	--	--	--	-107.05	205.19

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-0.90	-3.24	-4.12	-4.84	-4.76	-2.57
Cash EPS ($)	--	-3.08	-3.99	-4.71	-4.62	-2.53
Adjusted Book Value ($)	--	0.80	3.40	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.53	-3.21	-0.13	-3.68	-2.15
Free Cash Flow per Share ($)	--	-2.62	-3.42	-0.36	-4.07	-2.71

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-116.17	169.99	49.91	64.11	59.77
ROE (%)	-71.61	-155.76	132.63	46.15	59.26	54.32
ROA (%)	-21.91	-56.82	-52.60	-52.79	-45.47	-23.98
EBIT Margin (%)	-26.66	-7,785.74	-12,369.06	-21,324.23	-45,170.22	--
Net Margin (%)	-36.80	-7,308.51	-11,568.83	-20,041.91	-30,605.71	-4,172.99
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	4,882.82	0.26	0.99	1.92	--	--
EBIT Growth (%)	83.69	20.83	-15.58	-37.89	-98.51	-87.15
Net Profit Growth (%)	75.78	20.54	-15.01	-33.34	-100.02	-88.85
EPS Growth (%)	75.44	0.21	0.15	-0.02	-0.85	-0.84
Book Value Growth (%)	-19.27	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-1.89	-2.02	-3.51	-6.17	-34.40
Price / Book Value	0.76	7.68	2.45	-1.31	-2.80	-14.65
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.99	-1.16	-0.78	-1.65	-4.91	-29.29
Close Price ($)	1.12	6.11	8.31	17.01	29.33	88.29
High Price ($)	22.50	22.50	27.92	35.98	127.11	133.00
Low Price ($)	0.92	5.79	3.81	12.67	25.46	27.55
Market Cap ($ Cr)	76.57	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.94	0.20	-0.07	-0.08	-0.06
Short term debt to equity ratio	--	0.15	0.03	-0.02	-0.02	-0.03
Current Ratio	17.66	5.14	8.18	9.81	8.67	21.65
Quick Ratio	17.66	--	--	--	--	--
Interest Coverage	--	--	--	-33.26	-1,039.77	--

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	0.34	29.86	37.56	--	--	--
Asset Turnover	0.60	0.01	0.00	0.00	0.00	--
Receivable days	--	109.07	137.18	--	--	--
Inventory Days	--	--	--	--	--	-1,222.91
Payable days	--	46.28	84.68	139.46	319.38	562.33
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.